New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
›ETF Issuers›VanEck›BBH
BBH

VanEck Biotech ETF

The BBH Exchange Traded Fund (ETF) is provided by VanEck. It is built to track an index: MVIS US Listed Biotech 25 Index. The BBH ETF provides physical exposure, so by buying it you actually own parts of all the 24 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

Fund key info
Issuer
ISIN
US92189F7261
CUSIP
92189F726
Fund AuM
€350M
Share class AuM
€350M
Share class info
USD Distributing
TER
0.35%
Fund details
NAV· 7/10/2026
$205.51
1D NAV change
-2.20%
Dividend policy
Replication method
Replication model
No. of holdings
24
Inception date
12/20/2011
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Fund
Base currency
USD
Tax optimisation
PEA· France
UK Reporting Status· UK
Classification
Management strategy
Industry category
Asset class
Sector
Factors
Investment strategy
VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
Trading and listing info
$205.55
-$4.6 (-2.18%) 3 days ago
1:30 PM 07/10/26 · Closed
1D price range
$205.17$206.39
52W price range
$154.85$212.29
Exchange
Legal documents
Annual report
Factsheet
KIID
Prospectus
Name
VanEck
Number of funds
193
Total AuM
€230.01B

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight